1. Home
  2. NAMS vs ABM Comparison

NAMS vs ABM Comparison

Compare NAMS & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • ABM
  • Stock Information
  • Founded
  • NAMS 2019
  • ABM 1909
  • Country
  • NAMS Netherlands
  • ABM United States
  • Employees
  • NAMS N/A
  • ABM N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • ABM Diversified Commercial Services
  • Sector
  • NAMS Health Care
  • ABM Finance
  • Exchange
  • NAMS Nasdaq
  • ABM Nasdaq
  • Market Cap
  • NAMS 3.1B
  • ABM 2.8B
  • IPO Year
  • NAMS N/A
  • ABM N/A
  • Fundamental
  • Price
  • NAMS $40.29
  • ABM $43.13
  • Analyst Decision
  • NAMS Strong Buy
  • ABM Strong Buy
  • Analyst Count
  • NAMS 10
  • ABM 3
  • Target Price
  • NAMS $44.80
  • ABM $55.67
  • AVG Volume (30 Days)
  • NAMS 1.0M
  • ABM 508.0K
  • Earning Date
  • NAMS 11-05-2025
  • ABM 12-17-2025
  • Dividend Yield
  • NAMS N/A
  • ABM 2.46%
  • EPS Growth
  • NAMS N/A
  • ABM N/A
  • EPS
  • NAMS N/A
  • ABM 1.84
  • Revenue
  • NAMS $35,243,000.00
  • ABM $8,627,900,000.00
  • Revenue This Year
  • NAMS N/A
  • ABM $5.43
  • Revenue Next Year
  • NAMS N/A
  • ABM $3.15
  • P/E Ratio
  • NAMS N/A
  • ABM $23.34
  • Revenue Growth
  • NAMS 4.91
  • ABM 4.27
  • 52 Week Low
  • NAMS $14.06
  • ABM $40.00
  • 52 Week High
  • NAMS $41.47
  • ABM $58.18
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 61.84
  • ABM 51.46
  • Support Level
  • NAMS $36.59
  • ABM $41.56
  • Resistance Level
  • NAMS $40.88
  • ABM $42.74
  • Average True Range (ATR)
  • NAMS 2.59
  • ABM 0.99
  • MACD
  • NAMS -0.09
  • ABM 0.20
  • Stochastic Oscillator
  • NAMS 90.44
  • ABM 83.96

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

Share on Social Networks: